Pages that link to "Q44869749"
Jump to navigation
Jump to search
The following pages link to Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus (Q44869749):
Displaying 10 items.
- Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis (Q27022482) (← links)
- Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis (Q33762053) (← links)
- Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis (Q36207128) (← links)
- Pretreatment neutrophil-to-lymphocyte ratio in peripheral blood was associated with pulmonary tuberculosis retreatment (Q37675562) (← links)
- Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study (Q38627519) (← links)
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with laryngeal squamous cell carcinoma (Q40169794) (← links)
- Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8 T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer. (Q46002939) (← links)
- Background and Current Treatment of Squamous Cell Carcinoma of the Anus (Q50897271) (← links)
- Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) (Q64084335) (← links)
- C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy (Q91587443) (← links)